The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Serum neurofilament light protein predicts clinical outcome in traumatic brain injury
Open accessAbstract
Axonal white matter injury is believed to be a major determinant of adverse outcomes following traumatic brain injury (TBI). We hypothesized that measurement of neurofilament light protein (NF-L), a protein found in long white-matter axons, in blood samples, may serve as a suitable biomarker for neuronal damage in TBI patients. To test our hypotheses, we designed a study in two parts: i) we developed an immunoassay based on Single molecule array technology for quantification of NF-L in blood, and ii) in a proof-of-concept study, we tested our newly developed method on serial serum samples from severe TBI (sTBI) patients (n = 72) and controls (n = 35). We also compared the diagnostic and prognostic utility of NF-L with the established blood biomarker S100B. NF-L levels were markedly increased in sTBI patients compared with controls. NF-L at admission yielded an AUC of 0.99 to detect TBI versus controls (AUC 0.96 for S100B), and increased to 1.00 at day 12 (0.65 for S100B). Importantly, initial NF-L levels predicted poor 12-month clinical outcome. In contrast, S100B was not related to outcome. Taken together, our data suggests that measurement of serum NF-L may be useful to assess the severity of neuronal injury following sTBI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical Scale
JENNETT, B. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92830-5 · Cited by 7,501
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492
(1964) · The Lancet · doi:10.1016/s0140-6736(64)90810-4 · Cited by 2,898
WILSON, J. T. L., PETTIGREW, L. E. L., & TEASDALE, G. M. (1998) · Journal of Neurotrauma · doi:10.1089/neu.1998.15.573 · Cited by 2,386
Rissin, D. M., Kan, C. W., Campbell, T. G., Howes, S. C., Fournier, D. R., Song, L., Piech, T., Patel, P. P., Chang, L., Rivnak, A. J., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1641 · Cited by 2,119
Steyerberg, E. W., Mushkudiani, N., Perel, P., Butcher, I., Lu, J., McHugh, G. S., Murray, G. D., Marmarou, A., Roberts, I., Habbema, J. D. F., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050165 · Cited by 1,431
Collaborators, M. C. T. (2008) · BMJ · doi:10.1136/bmj.39461.643438.25 · Cited by 1,235
Maas, A. I. R., Hukkelhoven, C. W. P. M., Marshall, L. F., & Steyerberg, E. W. (2005) · Neurosurgery · doi:10.1227/01.neu.0000186013.63046.6b · Cited by 939
Clinical trials in head injury
Narayan, R. K., Michel, M. E., Ansell, B., Baethmann, A., Biegon, A., Bracken, M. B., Bullock, M. R., Choi, S. C., Clifton, G. L., Contant, C. F., et al. (2002) · Journal of Neurotrauma · doi:10.1089/089771502753754037 · Cited by 913
Kuhle, J., Barro, C., Andreasson, U., Derfuss, T., Lindberg, R., Sandelius, Å., Liman, V., Norgren, N., Blennow, K., & Zetterberg, H. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2015-1195 · Cited by 740
Self-citationThe Neuropathology and Neurobiology of Traumatic Brain Injury
Blennow, K., Hardy, J., & Zetterberg, H. (2012) · Neuron · doi:10.1016/j.neuron.2012.11.021 · Cited by 669
Self-citationMultivariable Prognostic Analysis in Traumatic Brain Injury: Results from The IMPACT Study
Murray, G. D., Butcher, I., McHugh, G. S., Lu, J., Mushkudiani, N. A., Maas, A. I. R., Marmarou, A., & Steyerberg, E. W. (2007) · Journal of Neurotrauma · doi:10.1089/neu.2006.0035 · Cited by 631
Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood
Zetterberg, H., Smith, D. H., & Blennow, K. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.9 · Cited by 596
Self-citationDiffuse Axonal Injury in Head Trauma
Smith, D. H., Meaney, D. F., & Shull, W. H. (2003) · Journal of Head Trauma Rehabilitation · doi:10.1097/00001199-200307000-00003 · Cited by 576
Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis
Lu, C.-H., Macdonald-Wallis, C., Gray, E., Pearce, N., Petzold, A., Norgren, N., Giovannoni, G., Fratta, P., Sidle, K., Fish, M., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001642 · Cited by 563
Self-citationZetterberg, H., Skillbäck, T., Mattsson, N., Trojanowski, J. Q., Portelius, E., Shaw, L. M., Weiner, M. W., Blennow, K., & Initiative, F. T. A. D. N. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2015.3037 · Cited by 487
Self-citationEarly prognosis in traumatic brain injury: from prophecies to predictions
Lingsma, H. F., Roozenbeek, B., Steyerberg, E. W., Murray, G. D., & Maas, A. I. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70065-x · Cited by 465
Blood Biomarkers for Brain Injury in Concussed Professional Ice Hockey Players
Shahim, P., Tegner, Y., Wilson, D. H., Randall, J., Skillbäck, T., Pazooki, D., Kallberg, B., Blennow, K., & Zetterberg, H. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.367 · Cited by 390
Self-citationNeurofilaments are obligate heteropolymers in vivo
Lee, M., Xu, Z., Wong, P., & Cleveland, D. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.6.1337 · Cited by 381
GFAP and S100B are biomarkers of traumatic brain injury: An observational cohort study
Vos, P. E., Jacobs, B., Andriessen, T. M. J. C., Lamers, K. J. B., Borm, G. F., Beems, T., Edwards, M., Rosmalen, C. F., & Vissers, J. L. M. (2010) · Neurology · doi:10.1212/wnl.0b013e3181fd62d2 · Cited by 367
Neurochemical Aftermath of Amateur Boxing
Zetterberg, H., Hietala, M. A., Jonsson, M., Andreasen, N., Styrud, E., Karlsson, I., Edman, Å., Popa, C., Rasulzada, A., Wahlund, L.-O., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.9.1277 · Cited by 356
Self-citationElevated neurofilament levels in neurological diseases
Norgren, N., Rosengren, L., & Stigbrand, T. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03219-0 · Cited by 351
Self-citationCSF-Biomarkers in Olympic Boxing: Diagnosis and Effects of Repetitive Head Trauma
Neselius, S., Brisby, H., Theodorsson, A., Blennow, K., Zetterberg, H., & Marcusson, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033606 · Cited by 275
Self-citationCSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
Skillbäck, T., Farahmand, B., Bartlett, J. W., Rosén, C., Mattsson, N., Nägga, K., Kilander, L., Religa, D., Wimo, A., Winblad, B., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000001015 · Cited by 263
Self-citationMeta-Analysis of APOE 4 Allele and Outcome after Traumatic Brain Injury
Zhou, W., Xu, D., Peng, X., Zhang, Q., Jia, J., & Crutcher, K. A. (2008) · Journal of Neurotrauma · doi:10.1089/neu.2007.0489 · Cited by 244
GFAP and S100B in the acute phase of mild traumatic brain injury
Metting, Z., Wilczak, N., Rodiger, L. A., Schaaf, J. M., & van der Naalt, J. (2012) · Neurology · doi:10.1212/wnl.0b013e318253d5c7 · Cited by 218
Magnoni, S., Esparza, T. J., Conte, V., Carbonara, M., Carrabba, G., Holtzman, D. M., Zipfel, G. J., Stocchetti, N., & Brody, D. L. (2012) · Brain · doi:10.1093/brain/awr286 · Cited by 170
Heins, S., Wong, P. C., Müller, S., Goldie, K., Cleveland, D. W., & Aebi, U. (1993) · The Journal of cell biology · doi:10.1083/jcb.123.6.1517 · Cited by 162
Nimer, F. A., Thelin, E. P., Nyström, H., Dring, A. M., Svenningsson, A., Piehl, F., Nelson, D., & Bellander, B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132177 · Cited by 143
Eikelenboom, M. J., Petzold, A., Lazeron, R. H. C., Silber, E., Sharief, M. K., Thompson, E. J., Barkhof, F., Giovannoni, G., Polman, C. H., & Uitdehaag, B. M. J. (2003) · Neurology · doi:10.1212/01.wnl.0000041496.58127.e3 · Cited by 136
INCREASED LEVELS OF SERUM S100B PROTEIN IN CRITICALLY ILL PATIENTS WITHOUT BRAIN INJURY
Routsi, C., Stamataki, E., Nanas, S., Psachoulia, C., Σταθόπουλος, Α., Koroneos, A., Zervou, M., Jullien, G., & Roussos, C. (2006) · Shock · doi:10.1097/01.shk.0000209546.06801.d7 · Cited by 120
Ljungqvist, J., Zetterberg, H., Mitsis, M., Blennow, K., & Skoglund, T. S. (2016) · Journal of Neurotrauma · doi:10.1089/neu.2016.4496 · Cited by 120
Self-citationSerum S-100B protein monitoring in patients with severe traumatic brain injury
Korfias, S. I., Stranjalis, G., Boviatsis, E., Psachoulia, C., Jullien, G., GREGSON, B. A., Mendelow, A. D., & Sakas, D. E. (2006) · Intensive Care Medicine · doi:10.1007/s00134-006-0463-4 · Cited by 116
Serum S100β increases in marathon runners reflect extracranial release rather than glial damage
Hasselblatt, M., Mooren, F. C., von Ahsen, N., Keyvani, K., Fromme, A., Schwarze-Eicker, K., Senner, V., & Paulus, W. (2004) · Neurology · doi:10.1212/01.wnl.0000123092.97047.b1 · Cited by 115
Stålnacke, B.-M., Ohlsson, A., Tegner, Y., & Sojka, P. A. (2006) · British Journal of Sports Medicine · doi:10.1136/bjsm.2005.021584 · Cited by 113
Self-citationThelin, E. P., Nelson, D., & Bellander, B. (2013) · Neurocritical Care · doi:10.1007/s12028-013-9916-0 · Cited by 101
New movements in neurofilament transport, turnover and disease
Barry, D. M., Millecamps, S., Julien, J., & Garcia, M. L. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.03.011 · Cited by 98
Review on intermediate filaments of the nervous system and their pathological alterations
Lépinoux-Chambaud, C., & Eyer, J. (2013) · Histochemistry and Cell Biology · doi:10.1007/s00418-013-1101-1 · Cited by 93
Kinetic modelling of serum S100b after traumatic brain injury
Ercole, A., Thelin, E. P., Holst, A., Bellander, B., & Nelson, D. (2016) · BMC Neurology · doi:10.1186/s12883-016-0614-3 · Cited by 90
Gatson, J. W., Barillas, J., Hynan, L. S., Diaz-Arrastia, R. R., Wolf, S. E., & Minei, J. P. (2014) · Journal of neurosurgery · doi:10.3171/2014.7.jns132474 · Cited by 89
Berger, R. P., Bazaco, M. C., Wagner, A. K., Kochanek, P. M., & Fabio, A. (2010) · Developmental Neuroscience · doi:10.1159/000316803 · Cited by 82
Outcome of Traumatic Brain Injury after Three Decades— Relationship to ApoE Genotype
Isoniemi, H., Tenovuo, O. S., Portin, R. I., Himanen, L., & Kairisto, V. (2006) · Journal of Neurotrauma · doi:10.1089/neu.2006.23.1600 · Cited by 71
Martínez‐Morillo, E., Childs, C., García, B. P., Menéndez, F. V. Á., Romaschin, A. D., Cervellin, G., Lippi, G., & Diamandis, E. P. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-0908 · Cited by 67
Nimer, F. A., Lindblom, R. P. F., Ström, M., Guerreiro‐Cacais, A. O., Parsa, R., Aeinehband, S., Mathiesen, T. I., Lidman, O., & Piehl, F. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.10.002 · Cited by 54
Tortorella, C., Direnzo, V., Taurisano, P., Romano, R., Ruggieri, M., Zoccolella, S., Mastrapasqua, M., Popolizio, T., Blasi, G., Bertolino, A., et al. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514546789 · Cited by 19
S-100βdoes not predict outcome after mild traumatic brain injury
Ryb, G. E., Dischinger, P. C., Auman, K. M., Kufera, J. A., Cooper, C. C., Mackenzie, C. F., & Kane, R. L. (2014) · Brain Injury · doi:10.3109/02699052.2014.919525 · Cited by 16
Research works printed but not linked: 2
- Raabe, A. et al. S-100B protein as a serum marker of secondary neurological complications in neurocritical care patients. Neurological research 26, 440–445, doi: 10.1179/016164104225015958 (2004). · doi:10.1179/016164104225015958
- Breiman, L., Friedman, J., Olshen, R. A. & Stone, C. I. Classification and Regression Trees. (Boca Raton:: FL CRC Press,, 1984).
Cited by
Neurofilaments as biomarkers in neurological disorders
Khalil, M., Teunissen, C. E., Otto, M., Piehl, F., Sormani, M. P., Gattringer, T., Barro, C., Kappos, L., Comabella, M., Fazekas, F., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0058-z · Cited by 1,988
Self-citationNeurofilament light chain as a biomarker in neurological disorders
Gaetani, L., Blennow, K., Calabresi, P., Di Filippo, M., Parnetti, L., & Zetterberg, H. (2019) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-320106 · Cited by 1,334
Self-citationSerum neurofilament light: a biomarker of neuronal damage in multiple sclerosis
Disanto, G., Barro, C., Benkert, P., Naegelin, Y., Schädelin, S., Giardiello, A., Zecca, C., Blennow, K., Zetterberg, H., Leppert, D., et al. (2017) · Annals of Neurology · doi:10.1002/ana.24954 · Cited by 1,164
Self-citationDominantly Inherited Alzheimer Network, Preische, O., Schultz, S. A., Apel, A., Kuhle, J., Kaeser, S. A., Barro, C., Gräber, S., Kuder-Buletta, E., LaFougere, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0304-3 · Cited by 927
Mattsson, N., Cullen, N. C., Andreasson, U., Zetterberg, H., & Blennow, K. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.0765 · Cited by 726
Self-citation
Metadata
- Authors
- Shahim, P., Gren, M., Liman, V., Andreasson, U., Norgren, N., Tegner, Y., Mattsson, N., Andreasen, N., Öst, M., Zetterberg, H., Nellgård, B., & Blennow, K.
- Venue
- Scientific Reports
- Published
- 2016-11-07
- Volume
- 6
- Issue
- 1
- Pages
- 36791-36791
- ISSN
- 2045-2322 (ISSN-L)
- OpenAlex
- W2550361609
- Cited by
- 348
- References
- 46
- FWCI
- 21.03
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.